The {pharmaceutical sector is rapidly exploring novel treatment methods for obesity , and the introduction of semaglutide 10mg doses represents the change. Healthcare providers are beginning to assess the likely benefits and drawbacks associated with this increased strength formulation , especially in contrast with existing less potent semaglutide